Oral Contraceptives and Orthodontic Treatment: What You Need to Know

How do hormones affect the mouth?

Sex hormones — particularly oestrogen and progesterone — have receptors in gingival (gum) tissue and influence how the gums respond to dental plaque. During periods of hormonal change, such as puberty, pregnancy, and the menstrual cycle, gum tissues can become more reactive to bacterial plaque, leading to increased inflammation, bleeding, and swelling even when plaque levels are low. This hormonal influence on the periodontium is well documented and explains why gum problems often become more apparent at specific life stages. Oral contraceptives introduce exogenous hormones that can replicate some of these effects.

Combined oral contraceptive pill and gingival inflammation

The combined oral contraceptive (COC) pill contains both synthetic oestrogen and progestogen. Early formulations used in the 1960s and 1970s contained much higher hormone doses than modern pills and were associated with significant gingival enlargement and pronounced inflammation. Studies from that era showed measurable differences in gingival health between COC users and non-users. Modern low-dose combined pills carry a much lower risk, but some evidence still links COC use with modestly increased gingival sensitivity and bleeding on probing compared to non-users with equivalent plaque levels. For patients undergoing orthodontic treatment — where appliances increase plaque retention — this effect compounds the already elevated risk of gingival inflammation around brackets and wires.

Progesterone-only pill — less gum effect

The progesterone-only pill (POP or mini-pill) contains progestogen without oestrogen. The evidence for gingival effects from the POP is considerably weaker than for the combined pill. While progestogen does have gingival effects in isolation — it is the dominant hormonal driver of pregnancy gingivitis — the lower doses in the POP appear to have minimal clinical impact on gum health in most patients. For patients who are concerned about oral health effects of hormonal contraception, discussing options with their GP is reasonable, though this decision should always be based on contraceptive efficacy and medical suitability first and oral health considerations second.

How gum disease affects orthodontics

Healthy gum and bone support is a prerequisite for safe orthodontic treatment. Periodontal inflammation — even gingivitis without bone loss — means that orthodontic forces are being applied in a compromised environment. Sustained gingival inflammation during fixed brace treatment is associated with increased risk of white spot lesions (early decay around brackets), hyperplastic gum tissue, and difficulty achieving precise tooth movement. In patients with pre-existing periodontitis (gum disease with bone loss), orthodontic treatment should only begin after the periodontitis is stabilised. For COC users who are more prone to gingival inflammation, proactive hygiene support is part of orthodontic care.

Debunking the antibiotic-pill interaction myth

A historically cited concern is that antibiotics prescribed in dental or orthodontic settings might reduce the effectiveness of the combined pill. This was based on a theoretical mechanism involving gut bacteria and oestrogen recycling. However, current UK guidance from the Faculty of Sexual and Reproductive Healthcare (FSRH) confirms that there is no clinically significant interaction between commonly prescribed antibiotics (including those used in dentistry, such as amoxicillin and metronidazole) and combined hormonal contraceptives. Patients no longer need to use additional contraception during a short course of non-enzyme-inducing antibiotics. This guidance applies to the vast majority of antibiotics. Enzyme-inducing drugs (such as rifampicin) are a different matter and do reduce pill effectiveness, but these are not used in routine orthodontic practice.

Bone metabolism and contraceptives — limited evidence

Orthodontic tooth movement depends on bone remodelling — the coordinated resorption and deposition of bone in response to pressure and tension from orthodontic forces. There is theoretical interest in whether hormonal contraceptives influence bone metabolism in a way that might affect tooth movement rates or treatment outcomes. Oestrogen generally has a bone-protective effect, and progesterone plays a role in bone formation. Some small studies have suggested that COC users may have slightly different bone turnover markers, but the clinical relevance to orthodontic tooth movement has not been established in adequately powered trials. Currently, there is no recommendation to modify orthodontic force levels or treatment planning based on COC use alone.

What should you tell your orthodontist?

Always tell your orthodontist what medications and contraceptives you are taking at the start of treatment and if you change them during treatment. This includes all oral contraceptive pills, hormonal patches, vaginal rings, implants, and hormonal IUDs. While the impact of most contraceptives on orthodontic treatment is modest, the information helps your orthodontist interpret your gum health, tailor your hygiene advice, and understand any unusual gingival responses. It also ensures that if antibiotics or any other medication is prescribed during treatment, potential interactions are considered.

Managing gum health during treatment

The most important action for COC users undergoing orthodontic treatment is meticulous oral hygiene. The combined effects of hormonal influence and appliance-related plaque retention make vigilant cleaning essential. This means brushing after every meal with a fluoride toothpaste, using interdental brushes around each bracket, and using a fluoride mouthwash at a different time to brushing. Regular scale and polish appointments with your dentist or hygienist — ideally every three to four months during active orthodontic treatment — help maintain gingival health. If gum bleeding or swelling persists despite good hygiene, an assessment by a periodontist or your dentist should be arranged before continuing treatment.

Special considerations with IUD, implant, and injection

Non-oral hormonal contraceptives — including the hormonal IUD (Mirena), the subdermal implant (Nexplanon), and the progesterone injection (Depo-Provera) — deliver progestogen locally or systemically at varying doses. The evidence for oral effects from these methods is limited. The hormonal IUD releases very low systemic levels and is unlikely to have meaningful gingival effects. The injection, which delivers higher systemic progestogen levels, may have more gum effect, but robust studies are lacking. For most patients using these methods, standard orthodontic hygiene advice applies and no specific modifications to treatment planning are required based on contraceptive method alone.

Useful related pages

This guide is for general information only. It is not a diagnosis, treatment plan, or substitute for advice from a registered dentist or orthodontist.